These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35763675)

  • 1. Prescribing trend of tapentadol in a Sydney local health district.
    Mirabella J; Ravi D; Chiew AL; Buckley NA; Chan BS
    Br J Clin Pharmacol; 2022 Sep; 88(9):3929-3935. PubMed ID: 35763675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sustained-release Opioids: Morphine, Oxycodone and Tapentadol].
    Takahashi Y; Iseki M
    Masui; 2015 Nov; 64(11):1133-40. PubMed ID: 26689063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute pain.
    Frampton JE
    Drugs; 2010 Sep; 70(13):1719-43. PubMed ID: 20731478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ready conversion of patients with well-controlled, moderate to severe, chronic malignant tumor-related pain on other opioids to tapentadol extended release.
    Imanaka K; Tominaga Y; Etropolski M; Ohashi H; Hirose K; Matsumura T
    Clin Drug Investig; 2014 Jul; 34(7):501-11. PubMed ID: 24906437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of discharge opioid on persistent postoperative opioid use: a retrospective cohort study comparing tapentadol with oxycodone.
    Lam T; Xia T; Biggs N; Treloar M; Cheng O; Kabu K; Stevens JA; Evans JD; da Gama ME; Lubman DI; Nielsen S
    Anaesthesia; 2023 Apr; 78(4):420-431. PubMed ID: 36535726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tapentadol. Acute or chronic pain: no therapeutic advance.
    Prescrire Int; 2014 May; 23(149):121-4. PubMed ID: 24926510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine.
    Ikenberg R; Hertel N; Moore RA; Obradovic M; Baxter G; Conway P; Liedgens H
    J Med Econ; 2012; 15(4):724-36. PubMed ID: 22364286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
    Gálvez R; Schäfer M; Hans G; Falke D; Steigerwald I
    Adv Ther; 2013 Mar; 30(3):229-59. PubMed ID: 23475406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids for cancer pain - an overview of Cochrane reviews.
    Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical opioid poisonings in Victoria, Australia: Rates and characteristics of a decade of emergency department presentations among nine pharmaceutical opioids.
    Lam T; Hayman J; Berecki-Gisolf J; Sanfilippo P; Lubman DI; Nielsen S
    Addiction; 2022 Mar; 117(3):623-636. PubMed ID: 34338377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of opioid prescribing upon hospital discharge in patients receiving tapentadol versus oxycodone following orthopaedic surgery.
    Wang X; Tay HP; Narayan SW; Penm J; Patanwala AE
    Int J Clin Pharm; 2021 Dec; 43(6):1602-1608. PubMed ID: 34089144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone.
    Haeseler G; Schaefers D; Prison N; Ahrens J; Liu X; Karch A
    BMC Anesthesiol; 2017 Jul; 17(1):91. PubMed ID: 28693439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of tapentadol immediate release versus oxycodone immediate release for acute post-operative pain after major hip surgeries.
    Wang X; Penm J; Patanwala AE
    Curr Med Res Opin; 2022 Jan; 38(1):115-121. PubMed ID: 34641744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study.
    Baron R; Likar R; Martin-Mola E; Blanco FJ; Kennes L; Müller M; Falke D; Steigerwald I
    Pain Pract; 2016 Jun; 16(5):580-99. PubMed ID: 26095455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tapentadol abuse potential: a postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment.
    Butler SF; McNaughton EC; Black RA
    Pain Med; 2015 Jan; 16(1):119-30. PubMed ID: 25243972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study.
    Morgan CL; Jenkins-Jones S; Currie C; Baxter G
    Adv Ther; 2019 Jun; 36(6):1412-1425. PubMed ID: 30963513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the norepinephrine transporter (NET) inhibition on μ-opioid receptor (MOR)-induced anti-nociception in a bone cancer pain model.
    Ono H; Nakamura A; Kanbara T; Minami K; Shinohara S; Sakaguchi G; Kanemasa T
    J Pharmacol Sci; 2014; 125(3):264-73. PubMed ID: 24965165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia.
    Lam T; Biggs N; Xia T; Evans J; Stevens J; da Gama M; Lubman DI; Nielsen S
    BMJ Open; 2022 Apr; 12(4):e060151. PubMed ID: 35418442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and tolerability of tapentadol prolonged release compared with prior opioid therapy for the management of severe, chronic osteoarthritis pain.
    Steigerwald I; Schenk M; Lahne U; Gebuhr P; Falke D; Hoggart B
    Clin Drug Investig; 2013 Sep; 33(9):607-19. PubMed ID: 23912473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid prescribing, pain, and hospital stay of general surgery patients with oxycodone allergies in South Australia.
    Kovoor JG; Bacchi S; Gupta AK; Vo T; Lam C; Lam L; Jiang M; Stretton B; To MS; Nann S; Ovenden CD; Hewitt JN; Goh R; Reid JL; Hugh TJ; Dobbins C; Hewett PJ; Trochsler MI; Kette FE; Maddern GJ
    ANZ J Surg; 2023 Nov; 93(11):2631-2637. PubMed ID: 37837230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.